12th European AIDS Society Conference (EACS), 11-14 November 2009, Cologne

21 February 2010. Related: Conference reports, Conference index, EACS 12 Cologne 2009.

Reports from the conference

Introduction

In this issue we continue reports from this European conference that is held every two years.

This year a comprehensive programme of lectures and sessions available as webcasts and podcasts and include many of the slide sets:

http://www.europeanaidsclinicalsociety.org

http://www.multiwebcast.com/eacs/2009/12th

Access requires a free one-time registration using the invitation code: EACS2009

It is disappointing that the abstracts from the meeting were not available online (as we went to press), and are only available as a subscription issue of HIV Medicine (2009, volume 10, issue S2).

[Note: abstracts have since been posted to the EACS abstract archive: http://www.abstractserver.com/eacsabstractarchive]

The following reports are included in this issue.

• Screening for anal cancer recommended for HIV-positive men

• Once-daily darunavir/r monotherapy is suboptimal as initial regimen in treatment-naive people

• Central fat accumulation remains a significant problem in patients starting HAART after 2005 with higher incidence in women compared to men

• Alendronate improves bone mineral density in
  HIV-positive people with osteoporosis at 96 weeks

• TMC278 did not show teratogenic potential in animal models

• Etravirine pregnancy data from five cases: no dose adjustment required

• No clinically relevant interactions between TMC278 and oral contraceptives (norethindrone plus ethinylestradiol)

• Gender-based differences in patients receiving antiretroviral therapy

• Pilot PK study of two generic paediatric formulations of lopinavir/ritonavir vs originator products

• Other selected PK and drug interaction summaries from EACS